Article Information
History
- January 19, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Alexander Muik1,
- Ann-Kathrin Wallisch1,
- Bianca Sänger1,
- Kena A. Swanson2,
- Julia Mühl1,
- Wei Chen2,
- Hui Cai2,
- Ritu Sarkar2,
- Özlem Türeci1,
- Philip R. Dormitzer2 and
- Ugur Sahin1,3,*
- 1BioNTech, An der Goldgrube 12, 55131 Mainz, Germany
- 2Pfizer, 401 N Middletown Rd., Pearl River, NY 10960, U.S.A.
- 3TRON gGmbH – Translational Oncology at the University Medical Center of the Johannes Gutenberg, University Freiligrathstraße 12, 55131 Mainz, Germany
- ↵*Correspondence to: Ugur.Sahin{at}biontech.de
Posted January 19, 2021.
Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera
